Tumor-specific IL-9–producing CD8<sup>+</sup>Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers
Crossref DOI link: https://doi.org/10.1073/pnas.1317431111
Published Online: 2014-01-27
Published Print: 2014-02-11
Update policy: https://doi.org/10.1073/pnas.cm10313
Lu, Yong
Hong, Bangxing
Li, Haiyan
Zheng, Yuhuan
Zhang, Mingjun
Wang, Siqing
Qian, Jianfei
Yi, Qing
Publication History
Published: 2014-01-27